These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1915428)

  • 21. Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial.
    Sanna G; Meoli P; Bianchini C; Rovelli F
    G Ital Cardiol; 1983; 13(3):145-51. PubMed ID: 6350090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of beta-blockade on the premature ventricular beats/heart rate relation and heart rate variability in patients with coronary heart disease and severe ventricular arrhythmias.
    Acanfora D; Pinna GD; Gheorghiade M; Trojano L; Furgi G; Maestri R; Picone C; Iannuzzi GL; Marciano F; Rengo F
    Am J Ther; 2000 Aug; 7(4):229-36. PubMed ID: 11486156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of pentisomide on stable ventricular premature beats. Comparison with placebo.
    Mangini SG; Mastropasqua F; Oldani V; Massari F; Maino GN; Ricci A; Scrutinio D; Rizzon P
    Eur Heart J; 1991 Jun; 12(6):712-9. PubMed ID: 1713557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN; Kaplinsky E; Kirsten E; Guerrero J
    Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heart rhythm changes in patients with chronic obstructive bronchopneumopathies: effects of different methylxanthine drugs].
    Cipri A; Pozzar F; Dini FL
    Minerva Cardioangiol; 1992; 40(1-2):31-9. PubMed ID: 1630668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the efficacy of propafenone and hydroquinidine in stabilized extrasystolic ventricular arrhythmia by means of dynamic electrocardiographic Holter monitoring].
    Rizzon P; De Toma L; Mangini SG; Lagioia R; Scrutinio D; Accettura D; De Nicolò M
    G Ital Cardiol; 1984 May; 14(5):345-51. PubMed ID: 6205924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is it possible to predict the anti-arrhythmic effect of beta blockers based on various relations between premature ventricular beat and the preceding cardiac cycle?].
    Pitzalis M; Massari F; Totaro P; Mastropasqua F; Rizzon P
    Cardiologia; 1992 Dec; 37(12):853-7. PubMed ID: 1284647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N; Terry L; Murphy ML; Thompson CH; Doherty JE; Sakhaii M; Dinh H
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: results of a prospective, controlled trial.
    Singh SN; DiBianco R; Gottdiener JS; Ginsberg R; Fletcher RD
    Am J Cardiol; 1984 Mar; 53(6):745-50. PubMed ID: 6367416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological effects of intravenous nicaïnoprol, a new antiarrhythmic agent, in 11 patients.
    Libersa CC; Caron JF; Kacet S; Dagano J; Vincent A; Dupuis B; Gayet JL; Lekieffre JP
    Eur Heart J; 1988 Mar; 9(3):271-8. PubMed ID: 3383868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atropine versus glycopyrrolate in eye surgery. A comparison of rhythm disorders and heart frequency using Holter-ECG].
    Braun GG; Schywalsky M; Naujoks B; Brunner M; Danner U; Hauschild S
    Anaesthesiol Reanim; 1992; 17(2):57-65. PubMed ID: 1418276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiarrhythmic drugs in chronic ventricular extrasystole (author's transl)].
    Klein G; Wirtzfeld A; Schlegel J; Himmler C; Neiss A
    Dtsch Med Wochenschr; 1980 Feb; 105(6):189-94. PubMed ID: 6153310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
    Härtel G
    Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition kinetics and dynamics of nicainoprol, a new antiarrhythmic agent, in humans.
    Ishizaki T; Horai Y; Kubota K; Minegishi A; Echizen H; Chiba K
    Clin Pharmacol Ther; 1987 Nov; 42(5):525-34. PubMed ID: 3677541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).
    Zuanetti G; Latini R; Neilson JM; Schwartz PJ; Ewing DJ
    J Am Coll Cardiol; 1991 Mar; 17(3):604-12. PubMed ID: 1899680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
    Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
    J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cibenzoline for treatment of ventricular arrhythmias: a double-blind placebo-controlled study.
    Kostis JB; Krieger S; Moreyra A; Cosgrove N
    J Am Coll Cardiol; 1984 Aug; 4(2):372-7. PubMed ID: 6376595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators.
    Zehender M; Meinertz T; Faber T; Caspary A; Jeron A; Bremm K; Just H
    J Am Coll Cardiol; 1997 Apr; 29(5):1028-34. PubMed ID: 9120155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.